| Title |
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, December 2011
|
| DOI | 10.1007/s10549-011-1895-2 |
| Pubmed ID | |
| Authors |
Laura J. Esserman, Donald A. Berry, Maggie C. U. Cheang, Christina Yau, Charles M. Perou, Lisa Carey, Angela DeMichele, Joe W. Gray, Kathleen Conway-Dorsey, Marc E. Lenburg, Meredith B. Buxton, Sarah E. Davis, Laura J. van’t Veer, Clifford Hudis, Koei Chin, Denise Wolf, Helen Krontiras, Leslie Montgomery, Debu Tripathy, Constance Lehman, Minetta C. Liu, Olufunmilayo I. Olopade, Hope S. Rugo, John T. Carpenter, Chad Livasy, Lynn Dressler, David Chhieng, Baljit Singh, Carolyn Mies, Joseph Rabban, Yunni-Yi Chen, Dilip Giri, Alfred Au, Nola Hylton, The I-SPY 1 TRIAL Investigators |
Mendeley readers
The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| Unknown | 223 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 50 | 22% |
| Student > Ph. D. Student | 34 | 15% |
| Other | 16 | 7% |
| Professor > Associate Professor | 16 | 7% |
| Student > Bachelor | 15 | 7% |
| Other | 53 | 23% |
| Unknown | 42 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 81 | 36% |
| Agricultural and Biological Sciences | 39 | 17% |
| Biochemistry, Genetics and Molecular Biology | 24 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Engineering | 5 | 2% |
| Other | 22 | 10% |
| Unknown | 49 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2017.
All research outputs
#7,475,808
of 22,854,458 outputs
Outputs from Breast Cancer Research and Treatment
#1,656
of 4,659 outputs
Outputs of similar age
#70,630
of 243,804 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#27
of 58 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,659 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,804 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.